Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atomoxetine Hydrochloride”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00548327
What this trial is testing

The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype

Who this might be right for
SchizophreniaMemory DisordersCognition Disorders
National Institute of Mental Health (NIMH) 11
Post-approval studies (Phase 4)Study completedNCT00218322
What this trial is testing

Effectiveness of ATMX in Treating Adolescents With ADHD and SUD

Who this might be right for
Attention Deficit Disorder With HyperactivitySubstance-Related Disorders
Massachusetts General Hospital 108
Post-approval studies (Phase 4)Study completedNCT03350659
What this trial is testing

Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH

Who this might be right for
Neurogenic Orthostatic Hypotension
Seoul National University Hospital 50
Post-approval studies (Phase 4)Study completedNCT00216918
What this trial is testing

Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 40
Early research (Phase 1)Study completedNCT02014064
What this trial is testing

Safety Study to Assess Atomoxetine With MA Abusers and Healthy Controls

Who this might be right for
Continuous Methamphetamine DependenceMethamphetamine Dependence in Remission
University of California, Los Angeles 41
Testing effectiveness (Phase 2)Study completedNCT02500732
What this trial is testing

Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope

Who this might be right for
Vasovagal Syncope
University of Calgary 57
Testing effectiveness (Phase 2)Study completedNCT01522404
What this trial is testing

Effects of Atomoxetine in Mild Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment
Emory University 39
Not applicableStudy completedNCT00561340
What this trial is testing

Study of the Effect of Calorie Supplementation on Growth in Young Children on ADHD Medication

Who this might be right for
ADHD
University of Nebraska 29
Very early researchStudy completedNCT00780650
What this trial is testing

Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine

Who this might be right for
Type 1 Diabetes
University of Maryland, Baltimore 56
Large-scale testing (Phase 3)Study completedNCT00191659
What this trial is testing

Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 200
Not applicableStudy completedNCT03154359
What this trial is testing

Atomoxetine PBPK-PD Clinical Study

Who this might be right for
ADHD
Children's Mercy Hospital Kansas City 51
Testing effectiveness (Phase 2)Looking for participantsNCT07577661
What this trial is testing

Combination Upper-Airway Electrical and Pharmacological Stimulation for Obstructive Sleep Apnea

Who this might be right for
Obstructive Sleep ApneaSleep-disordered Breathing
Brigham and Women's Hospital 24
Not applicableStudy completedNCT00529893
What this trial is testing

Efficacy of Atomoxetine in the Neuropsychological Tests Among Children With ADHD

Who this might be right for
Attention Deficit Disorder With Hyperactivity
National Taiwan University Hospital 30
Large-scale testing (Phase 3)Study completedNCT00260533
What this trial is testing

Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder

Who this might be right for
Generalized Social Phobia
University of California, San Diego 27
Large-scale testing (Phase 3)Study completedNCT00191009
What this trial is testing

Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 124
Large-scale testing (Phase 3)Ended earlyNCT00216281
What this trial is testing

Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia

Who this might be right for
Schizophrenia
Indiana University 126
Post-approval studies (Phase 4)Study completedNCT00406354
What this trial is testing

Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany

Who this might be right for
Attention Deficit Hyperactivity DisorderOppositional Defiant Disorder
Eli Lilly and Company 181
Large-scale testing (Phase 3)Study completedNCT00191386
What this trial is testing

Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD)

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 228
Testing effectiveness (Phase 2)Study completedNCT00611936
What this trial is testing

Effects of Atomoxetine Treatment in Humans

Who this might be right for
Stress
Yale University 10
Post-approval studies (Phase 4)Study completedNCT00918567
What this trial is testing

Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD

Who this might be right for
Attention Deficit Hyperactivity Disorder
State University of New York at Buffalo 56
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation